Seipel, K.; Spahr, S.M.; Shaforostova, I.; Bacher, U.; Nilius, H.; Pabst, T.
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy. Int. J. Mol. Sci. 2025, 26, 9905.
https://doi.org/10.3390/ijms26209905
AMA Style
Seipel K, Spahr SM, Shaforostova I, Bacher U, Nilius H, Pabst T.
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy. International Journal of Molecular Sciences. 2025; 26(20):9905.
https://doi.org/10.3390/ijms26209905
Chicago/Turabian Style
Seipel, Katja, Sophia Maria Spahr, Inna Shaforostova, Ulrike Bacher, Henning Nilius, and Thomas Pabst.
2025. "Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy" International Journal of Molecular Sciences 26, no. 20: 9905.
https://doi.org/10.3390/ijms26209905
APA Style
Seipel, K., Spahr, S. M., Shaforostova, I., Bacher, U., Nilius, H., & Pabst, T.
(2025). Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy. International Journal of Molecular Sciences, 26(20), 9905.
https://doi.org/10.3390/ijms26209905
